BenzingaOctober 12, 2026 at 3:30 AM NY15 Days Ago
HC Wainwright & Co. Reiterates Buy on Compugen, Maintains $4 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Compugen (NASDAQ:CGEN) with a Buy and maintains $4 price target.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
